S Arumugam-Somasundaram

168 Maniktala Main Road
Kolkata, WB 700054, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 88 publications

Intranasal dalfampridine-loaded mucoadhesive polymeric nanoparticles for brain targeting: formulation and therapeutic evaluation in a cuprizone-induced demyelination model.

Intranasal dalfampridine-loaded mucoadhesive polymeric nanoparticles for brain targeting: formulation and therapeutic evaluation in a cuprizone-induced demyelination model.

Journal: Journal of drug targeting

Published: June 11, 2026

Protective Effects of Sitagliptin on Dextran Sulfate Sodium-Induced Colitis via Modulation of Inflammatory and Oxidative Stress.

Protective Effects of Sitagliptin on Dextran Sulfate Sodium-Induced Colitis via Modulation of Inflammatory and Oxidative Stress.

Journal: Medicina (Kaunas, Lithuania)

Published: April 10, 2026

Anti-Ulcer Effect of Ornithogalum umbellatum at Various Potencies in Indomethacin-Induced Gastric Ulceration in Sprague-Dawley Rats: A Pre-clinical Study.

Anti-Ulcer Effect of Ornithogalum umbellatum at Various Potencies in Indomethacin-Induced Gastric Ulceration in Sprague-Dawley Rats: A Pre-clinical Study.

Journal: Homeopathy : the journal of the Faculty of Homeopathy

Published: February 09, 2026

Antibody display technologies from phages to cells: translational bottlenecks and AI-enabled opportunities.

Antibody display technologies from phages to cells: translational bottlenecks and AI-enabled opportunities.

Journal: Frontiers in bioengineering and biotechnology

Published: February 04, 2026

Reconstructing the complex architecture of the genome with molecular scissors: applying genome editing technology in precision medicine.

Reconstructing the complex architecture of the genome with molecular scissors: applying genome editing technology in precision medicine.

Journal: Frontiers in genome editing

Published: December 07, 2025

Chitosan coated yeast microcapsules for efficient delivery of cefadroxil for the treatment of inflammatory bowel disease.

Chitosan coated yeast microcapsules for efficient delivery of cefadroxil for the treatment of inflammatory bowel disease.

Journal: International journal of biological macromolecules

Published: August 22, 2025

Chitosan nanoparticles of rutin mitigated histological changes induced in DNCB-induced colitis by enhanced modulation of inflammation and oxidative stress.

Chitosan nanoparticles of rutin mitigated histological changes induced in DNCB-induced colitis by enhanced modulation of inflammation and oxidative stress.

Journal: Journal of molecular histology

Published: May 03, 2025

Corrigendum to "Indigenous wisdom of a Kwatha to treat NASH: An insight into the mechanism" [J. Ethnopharmacol. 326 (2024) 117935].

Corrigendum to "Indigenous wisdom of a Kwatha to treat NASH: An insight into the mechanism" [J. Ethnopharmacol. 326 (2024) 117935].

Journal: Journal of ethnopharmacology

Published: April 13, 2025

Beyond obesity: lean metabolic dysfunction-associated steatohepatitis from unveiling molecular pathogenesis to therapeutic advancement.

Beyond obesity: lean metabolic dysfunction-associated steatohepatitis from unveiling molecular pathogenesis to therapeutic advancement.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: February 28, 2025

Editorial: Methods in experimental pharmacology 2023.

Editorial: Methods in experimental pharmacology 2023.

Journal: Frontiers in pharmacology

Published: November 20, 2024

Ellagic acid-imbedded MoO3 nanowires architecture: External mediator-less electrochemical immunoprobing of inflammatory bowel disease marker.

Ellagic acid-imbedded MoO3 nanowires architecture: External mediator-less electrochemical immunoprobing of inflammatory bowel disease marker.

Journal: Biosensors & bioelectronics

Published: October 22, 2024

MicroRNA: A Novel Class of Potential Biomarkers and Therapeutic Target for Non-Alcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.

MicroRNA: A Novel Class of Potential Biomarkers and Therapeutic Target for Non-Alcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.

Journal: MicroRNA (Shariqah, United Arab Emirates)

Published: October 16, 2024

Showing 1-12 of 88

Last Updated: 09/26/2026